# Extracting Your Intervention Discovery and Validation Formula

## Scope, data sources, and what can and cannot be inferred

This report reconstructs the "formula" and mindset you use to discover
and validate candidate interventions for a health condition by
extracting decision rules from the material you provided (your free-form
narrative + video transcript excerpts + the uploaded PDF slide/handout).
fileciteturn0file0

I do **not** have access to your broader cross-chat "ChatGPT history"
outside this thread; therefore, anything that is not present in the text
you pasted (or the uploaded PDF) cannot be extracted or confirmed here,
and the framework below should be treated as a *first-pass codification*
of your method rather than a complete forensic reconstruction of
everything you have ever done.

Because your request is methodological (how you generate and validate
hypotheses and interventions), this report focuses on (i) epistemic
structure, (ii) validation logic, (iii) how you translate signatures
into interventions, and (iv) how to harden the method against known
pitfalls in microbiome/omics inference. This is not individualized
medical advice. The clinical evidence examples cited below are used to
illustrate the validation pattern and its limits, not to recommend care.
[\[1\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)

## Your core mindset as a coherent research stance

Across your materials, your mindset is best described as
**constraint-based, ecosystem-level causal inference**: you treat a
condition as the emergent outcome of interacting subsystems (microbes,
metals, diet/exposome, host defenses, ecology, co-infections), then you
accept an intervention only if it is consistent with multiple
*independent* lines of evidence and does not break the system's internal
logic.

Three recurring cognitive commitments organize your approach:

First, you adopt **triangulation** as a default epistemic standard: you
increase confidence when *different approaches with different bias
structures* converge on the same conclusion, and you downgrade
confidence when convergent patterns fail. This is closely aligned with
"triangulation in aetiological epidemiology," which explicitly frames
triangulation as integrating evidence from approaches with *largely
unrelated key biases* to strengthen causal inference.
[\[2\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)

Second, you operate with an implicit **causal plausibility filter** (not
just statistical association). You are repeatedly asking "does this make
sense mechanistically in the full system?"---a stance that echoes
classic cautions about confusing association for causation and the use
of multi-viewpoint reasoning (often summarized via Bradford Hill's
considerations) when mapping exposures to outcomes.
[\[3\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC1898525/?utm_source=chatgpt.com)

Third, your reasoning is **anti-silo and anomaly-driven**: you look for
"weird" or "too-specific" changes (e.g., a single taxon that "shouldn't"
be down unless something selectively targeted it) and treat those
anomalies as signals of hidden exposures or hidden constraints. This is
a recognizable pattern in systems-style inference: anomalies are often
the most informative datapoints because they constrain the space of
plausible causal stories.
[\[4\]](https://www.cambridge.org/core/journals/psychological-medicine/article/causal-inference-with-observational-data-the-need-for-triangulation-of-evidence/AF5F7918753DF50F26B1D49561F0DF83?utm_source=chatgpt.com)

## The formula you are using in explicit, reproducible form

Your "big pattern" can be formalized as a **triangulated
signature--intervention validation loop**, which is also a
**self-falsifying model**: any contradiction forces revision or
rejection of the model/intervention.

### Core objects

Let:

-   **D** = a health condition (the target phenotype: symptoms,
    biomarkers, imaging endpoints, clinical outcomes).
-   **S** = a *signature* (your term), but operationally a structured
    set of features:\
    **S = { (fᵢ, directionᵢ, roleᵢ) }**, where each feature fᵢ can be a
    taxon shift, metabolite deficit, metalomic pattern, host
    "nutritional immunity" marker, ecological state (hypoxia), or
    exposure source.
-   **I** = a candidate intervention (dietary change, drug, prebiotic,
    probiotic, chelator, oxygenation strategy, etc.).
-   **E(I → fᵢ)** = evidence that I moves feature fᵢ in the intended
    direction (mechanistic, in vitro, animal, human translational).
-   **E(I → D)** = evidence that I changes the clinical phenotype D
    (clinical trials, observational cohorts, case series with credible
    endpoints).
-   **C(S)** = internal coherence constraints: the system must make
    sense ecologically and physiologically (no "broken triangles").

### The "triangle test" (your primary validation operator)

You repeatedly construct and test triangles of the form:

**I ──► fᵢ ──► D**\
and then verify (ideally) the third edge via independent data:

**I ──► D**

In words:\
1) choose an intervention I that you already know affects a feature fᵢ
(often a pathogen or ecological condition),\
2) check whether I is clinically associated with improvement in D, and\
3) accept validation only if the edges are directionally consistent (and
preferably supported by mechanistic plausibility).

This matches the logic of "evidence triangulation": confidence increases
when distinct evidence streams converge; confidence drops when one edge
fails.
[\[5\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)

### The "break condition" (self-falsification rule)

Your negative-control logic is strong and unusually explicit: if the
system predicts "I should help D because it reduces fᵢ," but in fact
credible clinical evidence shows I worsens D (or fails with a consistent
negative signal), you do not merely discard I---you treat it as evidence
that **something in S or the assumed causal link fᵢ → D is wrong**, and
you scrap/rebuild until the full set of relationships is coherent.

That is functionally analogous to insisting on a causal model satisfying
multiple Bradford-Hill--style viewpoints (coherence, plausibility,
consistency, etc.) rather than relying on a single association.
[\[3\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC1898525/?utm_source=chatgpt.com)

### The minimum "validated intervention" criterion implied by your method

Although you do not present a numeric scoring system in the transcripts,
your acceptance threshold can be stated as:

An intervention **I** is *validated within your framework* when:

-   **Target validation:** there is credible evidence I moves at least
    one load-bearing signature feature in the predicted direction (I →
    fᵢ),
    [\[6\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
-   **Clinical validation:** there is credible evidence I improves
    relevant endpoints in D (I → D),
    [\[2\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
-   **System coherence:** the intervention's effects do not violate the
    ecological/physiological story induced by S (no broken edges), and
    the story remains consistent with known constraints of microbiome
    study reproducibility and confounding risks.
    [\[7\]](https://www.nature.com/articles/s41591-021-01552-x?utm_source=chatgpt.com)

A key feature is that you treat **clinical evidence from "somewhere
else" as a validator of the model**, not as something separate from
mechanism. This is exactly what triangulation is meant to do: use
different evidence streams with different bias profiles to reduce the
chance you are being fooled by a single biased stream.
[\[2\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)

## The knowledge primitives that power your hypothesis generation

Your framework is not only "taxa up / taxa down." It depends on a
library of *functional and ecological primitives* that you repeatedly
reuse across conditions to generate interventions and predictions.

### Metal-driven ecology and microbial metallomics as a generator of "Achilles' heels"

A central primitive in your approach is: **metals are selective
pressures**. You repeatedly treat a tissue metal pattern
(iron/zinc/nickel/cadmium/lead, etc.) as an upstream driver that selects
for organisms with metal tolerance systems, efflux pumps,
toxin--antitoxin stress systems, or metal-dependent virulence enzymes.

This is consistent with broader literature on how dietary/host metal
availability shapes host--microbe dynamics and pathogen fitness.
[\[8\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC6007885/?utm_source=chatgpt.com)

Within this, you repeatedly search for **metal dependencies** that
create intervention leverage. Nickel is a particularly strong example
because many pathogens rely on nickel enzymes (notably urease and
\[NiFe\]-hydrogenases), and nickel homeostasis is a recognized
virulence-relevant constraint in multiple organisms.
[\[9\]](https://www.mdpi.com/2304-6740/7/7/80?utm_source=chatgpt.com)

You also reference methanogens as nickel-hungry organisms; this is
directionally correct: methanogenesis depends on nickel-containing
cofactors such as coenzyme F430 in methyl--coenzyme M reductase, and
nickel is incorporated across methanogens studied (including
*Methanobrevibacter smithii*).
[\[10\]](https://pubmed.ncbi.nlm.nih.gov/7298577/?utm_source=chatgpt.com)

### Nutritional immunity as an interpretive constraint on supplementation and interventions

Another primitive is that host biomarkers can be "host defense" rather
than "nutritional deficiency," and therefore the "obvious"
supplementation can be contraindicated in a pathogen-driven ecology.

In mainstream immunology, **nutritional immunity** describes host
strategies that restrict pathogen access to key nutrient metals (iron,
zinc, manganese) using proteins including calprotectin, lactoferrin,
hepcidin-regulated ferroportin control, and lipocalin-2--mediated
sequestration of siderophores.
[\[11\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC2847644/?utm_source=chatgpt.com)

Two implications you repeatedly draw are supported as general principles
(even though any disease-specific application requires careful
evidence):

-   **Calprotectin** can sequester manganese and (in many contexts)
    zinc, limiting microbial growth.
    [\[12\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC2847644/?utm_source=chatgpt.com)
-   **Hepcidin elevation** is a core mechanism of anemia of
    inflammation/functional iron deficiency via iron sequestration and
    reduced absorption (through ferroportin control); thus, "low serum
    iron" does not automatically mean "give iron," especially in
    inflammatory or infection-linked states.
    [\[13\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC4993159/?utm_source=chatgpt.com)

This matches your stance that supplementation can "feed the wrong side"
of the ecology when the host is actively restricting metals to constrain
pathogens.
[\[14\]](https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2014.00002/full?utm_source=chatgpt.com)

### Mismetallation and toxic metal displacement as upstream disturbance

You also invoke "mismetallation" and toxic metal entry through calcium
pathways as upstream events that can reorganize cellular and microbial
ecosystems.

The term **mismetallation** is established in microbiology/biochemistry
as incorrect metal occupancy of enzymes---often triggered or amplified
by oxidative stress---leading to loss of function and metabolic
bottlenecks.
[\[15\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC4192467/?utm_source=chatgpt.com)

For toxic metals, it is also well-supported that **cadmium can mimic
calcium** and enter via calcium channels/transport processes, disrupting
signaling and promoting oxidative stress.
[\[16\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC11209188/?utm_source=chatgpt.com)\
Lead also interacts with calcium-related pathways; voltage-dependent
calcium channels are implicated in heavy-metal permeation, though the
exact uptake routes differ by metal and context.
[\[17\]](https://hero.epa.gov/reference/4648041/?utm_source=chatgpt.com)

You additionally point to combined cadmium/lead oxidative stress; the
literature supports oxidative stress as a shared pathway for each metal
individually, and there is also literature on combined exposure effects
(with mixture behavior depending on dose/context).
[\[18\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC3087445/?utm_source=chatgpt.com)

### Restoring missing functions, not just suppressing "bad taxa"

A major distinctive feature of your method is that "fixing" a signature
requires **two-sided engineering**:

-   suppress or displace overrepresented opportunists/pathogens, *and*
-   restore missing beneficial functions (especially metabolite
    producers), with attention to ecology and anatomical site.

This aligns with mainstream understanding that fermentable fibers and
prebiotics have **structure-dependent fermentation kinetics** and can
shift fermentation location and outputs (including SCFA patterns).
Evidence supports that different fibers and fiber mixtures can shape
distal vs proximal fermentation and SCFA production.
[\[19\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC8726743/?utm_source=chatgpt.com)

Your specific emphasis on "molecular weight matters" for prebiotic
choice also has support: PHGG (partially hydrolyzed guar gum) molecular
weight can measurably alter microbiota and fermentation outcomes, and
some studies explicitly interpret PHGG as sustaining distal microbiota
metabolism and SCFA production (though details vary by model).
[\[20\]](https://www.sciencedirect.com/science/article/pii/S0023643825010667?utm_source=chatgpt.com)

### Cross-kingdom interactions and "functional shielding" as an intervention lever

You repeatedly treat persistent states (e.g., chronic gingivitis) as
potentially maintained by **polymicrobial cooperation**, including
fungal--bacterial biofilms that protect key pathogens from immune
recognition or antibiotic pressure.

This has direct experimental support in at least one well-known
periodontal context: work titled *"Candida albicans shields the
periodontal killer Porphyromonas gingivalis from recognition by the host
immune system..."* reports immune shielding and enhanced infection
dynamics in mixed biofilms.
[\[21\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC7139284/?utm_source=chatgpt.com)\
More broadly, the polymicrobial biofilm literature supports that
*Candida* readily forms mixed biofilms with bacteria, often changing
virulence and host response.
[\[22\]](https://www.mdpi.com/2309-608X/6/1/5?utm_source=chatgpt.com)

Your intervention pattern here is consistent: sometimes the most
effective lever is not directly targeting the "headline bacterium," but
removing the *shielding partner* that makes it persist.
[\[23\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC7139284/?utm_source=chatgpt.com)

## How you validate and debug the model in practice

### Why your method is "self-validating" in a specific technical sense

Your framework self-validates because it enforces **multi-constraint
satisfaction**: a candidate intervention must match (i) directional
effects on the signature, (ii) clinical outcomes, and (iii) ecological
plausibility. Any failed constraint is treated as informative error.

This is formally aligned with evidence triangulation logic: when
different approaches with unrelated biases converge, causal confidence
increases; when they diverge, one should investigate which
bias/mechanism explains the divergence rather than forcing a conclusion.
[\[5\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)

### Why this is especially important in microbiome/omics work

Your insistence on cross-validation is particularly defensible in
microbiome research because reproducibility is challenged by:

-   protocol variation (sampling, extraction, sequencing, pipelines),
    [\[24\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC12010094/?utm_source=chatgpt.com)
-   regional/demographic variability that limits universal "reference
    ranges,"
    [\[25\]](https://www.cell.com/cell/fulltext/S0092-8674%2824%2901038-9?utm_source=chatgpt.com)
-   and case--control design vulnerabilities (confounding, selection,
    measurement artifacts).
    [\[26\]](https://www.sciencedirect.com/science/article/abs/pii/S1047279716300795?utm_source=chatgpt.com)

These realities make the "single study → single list of taxa →
intervention" pipeline fragile, and make your "triangle + coherence +
break-on-contradiction" logic a rational attempt to counteract those
fragilities.
[\[27\]](https://www.nature.com/articles/s41591-021-01552-x?utm_source=chatgpt.com)

### A practical validation checklist extracted from your behavior

Condensing your method into an operational checklist yields the
following *implicit* rules (stated here as observables):

-   You do not treat a taxon change as actionable until you can describe
    at least one plausible **mechanistic role** (virulence traits,
    cofactor dependencies, metabolic outputs, oxygen tolerance, biofilm
    behavior, immune interactions).
    [\[28\]](https://www.mdpi.com/2304-6740/7/7/80?utm_source=chatgpt.com)
-   You prioritize interventions that target **dependencies** rather
    than just organism names (e.g., metal restriction/chelation for
    nickel enzymes; oxygenation strategies for obligate
    anaerobe-dominant ecologies).
    [\[29\]](https://www.mdpi.com/2304-6740/7/7/80?utm_source=chatgpt.com)
-   You require at least one **external clinical anchor**: some clinical
    investigation, cohort signal, or well-described clinical endpoint
    shift that matches the predicted direction.
    [\[30\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
-   You treat contradictions as evidence of upstream model error, not as
    "noise," and you rebuild accordingly. This is consistent with modern
    causal-inference discussions emphasizing that observational data
    need triangulation because any single approach can be wrong due to
    confounding/selection/measurement bias.
    [\[31\]](https://www.cambridge.org/core/journals/psychological-medicine/article/causal-inference-with-observational-data-the-need-for-triangulation-of-evidence/AF5F7918753DF50F26B1D49561F0DF83?utm_source=chatgpt.com)

## Worked examples showing your triangulation logic in action

The goal here is not to argue that any one intervention is "the answer,"
but to show how your validation operator behaves when confronted with
real evidence.

### Low-nickel diet as a triangle: nickel sensitivity ↔ symptoms ↔ diet restriction

In your narrative, the low-nickel diet example functions as a clean
triangle because:

-   it can plausibly reduce nickel exposure (a feature-level lever),
    [\[32\]](https://nickelinstitute.org/en/science/human-health-fact-sheets/fact-sheet-6-low-nickel-diet/?utm_source=chatgpt.com)
-   nickel sensitivity (including mucosal/contact-type phenomena) can be
    tested and phenotype-stratified (improving model identifiability),
    [\[33\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC7071203/?utm_source=chatgpt.com)
-   and there is at least pilot clinical evidence in
    endometriosis-associated IBS-like symptom cohorts reporting
    improvement after a low-nickel diet (open-label, with
    completion/selection limitations).
    [\[34\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC7071203/?utm_source=chatgpt.com)

This is a good illustration of how your method treats "mechanism
unclear" not as a blocker, but as a solvable gap: if the clinical anchor
exists and the exposure lever is real, you accept provisional validation
while continuing to refine the mechanistic story.
[\[35\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)

### Hyperbaric oxygen therapy as a triangle: hypoxia/anaerobiosis ↔ lesion biology ↔ oxygenation

You explicitly use HBOT as an "Achilles' heel" intervention when the
ecology implies hypoxia and anaerobe persistence.

There is animal-model evidence that hyperbaric oxygen treatment can
reduce endometriosis lesion burden in rats (a remission signal in that
model), which supplies an external anchor for your oxygen-based lever
hypothesis.
[\[36\]](https://pubmed.ncbi.nlm.nih.gov/21960508/?utm_source=chatgpt.com)

Within your framework, that does not prove human efficacy (you also say
it has not been clinically investigated in humans), but it is exactly
the kind of cross-evidence you use: ecological rationale + experimental
model outcome → "strong candidate for further validation."
[\[37\]](https://pubmed.ncbi.nlm.nih.gov/21960508/?utm_source=chatgpt.com)

### NAC as a triangle: oxidative stress/thiol depletion ↔ inflammatory phenotype ↔ glutathione precursor intervention

You frequently map "infectious/inflammatory state" to oxidative stress
and glutathione-related depletion, then treat NAC as a rational lever.

Independent of your narrative, NAC has been investigated clinically in
endometriosis contexts; multiple studies report improvements in
pain-related endpoints and/or endometrioma measures, though study
designs vary (including observational designs and non-comparative
trials).
[\[38\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC3662115/?utm_source=chatgpt.com)

Methodologically, NAC is a useful example because it shows a second
pattern in your approach: you do not require the intervention to be
"microbiome-specific" to include it; you only require that it fits the
broader ecological/host-defense constraints and shows clinical
triangulation.
[\[39\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)

### Biofilm logic and drug repurposing: metformin as an anti-virulence probe

You use metformin as an example of searching for evidence that a drug
has anti-biofilm or anti-virulence effects, then using that to explain
downstream benefits.

This is directionally supported in the antimicrobial/anti-virulence
literature: metformin has been reported to inhibit quorum
sensing--regulated virulence and reduce biofilm formation in
*Pseudomonas aeruginosa* models, among others (mostly preclinical and
mechanistic in scope, not disease-specific to endometriosis).
[\[40\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5656202/?utm_source=chatgpt.com)

In your framework, this kind of evidence is treated as "edge support" (I
→ biofilm feature), which then motivates the search for I → D evidence
in the target condition. This is structurally consistent with
triangulation, but it also highlights where your method must guard
against overgeneralization: anti-biofilm effects in one organism/model
do not automatically map to a different organism, tissue site, or
clinical phenotype without additional anchoring.
[\[41\]](https://link.springer.com/article/10.1007/s10654-024-01194-6?utm_source=chatgpt.com)

## Limitations, error modes, and how to harden your method without losing its power

Your approach is unusually strong at generating hypotheses that are
"clinically intelligible" and mechanistically constrained. The main
risks are not in the triangulation logic itself, but in **which evidence
streams get treated as independent**, and in **how signatures are
defined under high heterogeneity**.

### Independence is the key fragility in triangulation

Triangulation only strengthens inference if the combined approaches
truly have *different, largely unrelated* key biases. If two evidence
streams share the same confounder (e.g., diet pattern correlated with
socioeconomic status, or antibiotic exposure correlated with disease
severity), convergence can be illusory.
[\[42\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)

A practical hardening step is to explicitly label each edge with its
most likely bias class (confounding, selection, measurement), consistent
with newer "evidence triangulation" frameworks.
[\[43\]](https://link.springer.com/article/10.1007/s10654-024-01194-6?utm_source=chatgpt.com)

### Microbiome signatures are notoriously sensitive to design choices

Your critique of purely list-based signatures is consistent with the
microbiome methods literature: variability in methods can meaningfully
change measured community composition, and reporting/standardization
concerns are serious enough that dedicated reporting checklists (e.g.,
STORMS) were created to improve comparability and interpretability.
[\[44\]](https://www.nature.com/articles/s41591-021-01552-x?utm_source=chatgpt.com)

A hardening move compatible with your style is to treat "signature" as
**multi-layered** (taxa + functions + ecological state + host markers)
and to downgrade confidence for taxa-only claims unless supported by
function-level signals or repeated across populations.
[\[45\]](https://www.cell.com/cell/fulltext/S0092-8674%2824%2901038-9?utm_source=chatgpt.com)

### Some domain claims require careful correction when formalizing your framework

When codifying your method for others, it helps to correct a few
taxonomy/terminology slips because they can break reproducibility when
someone else tries to execute your workflow:

-   **Group B strep is *Streptococcus agalactiae***; *Streptococcus
    pyogenes* is Group A.
    [\[46\]](https://www.pasteur.fr/en/medical-center/disease-sheets/group-and-b-streptococcus?utm_source=chatgpt.com)
-   "Hesperidin" in your spoken example appears to be a slip for
    **hepcidin** (the iron-regulatory hormone central to anemia of
    inflammation).
    [\[47\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC4993159/?utm_source=chatgpt.com)

These do not change your method; they just matter for
operationalization.

### Probiotic examples illustrate why "mechanism + clinical" must include safety scrutiny

You mention *E. coli* Nissle 1917 as a beneficial competitor. The
literature supports that it can compete with pathogens in the inflamed
gut via iron acquisition and can reduce *Salmonella* burden in models,
which is consistent with your "nutrient competition" lens.
[\[48\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC3752295/?utm_source=chatgpt.com)

At the same time, there are credible safety/biological complexity
nuances: *E. coli* Nissle 1917 carries the **colibactin** genotoxicity
island, raising legitimate concerns about long-term risk contexts and
motivating engineered derivatives that preserve antagonism without
genotoxicity.
[\[49\]](https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1008029&utm_source=chatgpt.com)\
This aligns with your own meta-principle: an intervention is not
"validated" if any critical piece breaks---safety is one of those
pieces.
[\[50\]](https://link.springer.com/article/10.1007/s10654-024-01194-6?utm_source=chatgpt.com)

### A concrete template that preserves your method while improving reproducibility

If you want your "formula" to be executable by other researchers (or by
your future self under time pressure), the most faithful codification is
an **evidence--constraint matrix** built around your triangle test:

For each candidate I:

1\) **Signature linkage**: which fᵢ does I change, and what is the
evidence class (in vitro / animal / human mechanistic / human
intervention)?
[\[51\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)\
2) **Clinical anchoring**: what endpoints in D have been tested, and
what is the design quality (RCT, quasi-experimental, cohort,
open-label)?
[\[52\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC12192176/?utm_source=chatgpt.com)\
3) **Coherence constraints**: does I violate nutritional immunity logic,
ecological plausibility, or known host-pathogen competition?
[\[53\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC4993159/?utm_source=chatgpt.com)\
4) **Disconfirmers**: list the strongest credible results that would
break the model (your "scrap it if it breaks" rule).
[\[54\]](https://www.cambridge.org/core/journals/psychological-medicine/article/causal-inference-with-observational-data-the-need-for-triangulation-of-evidence/AF5F7918753DF50F26B1D49561F0DF83?utm_source=chatgpt.com)

This format is essentially your method, made inspectable.

If you provide additional transcripts or example "case walkthroughs"
where you applied the method end-to-end (including failures), the
framework above can be tightened into a more formal *algorithmic
specification* (with explicit stopping rules, evidence thresholds, and
bias annotations) while staying faithful to your original mindset.

[\[1\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
[\[2\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
[\[5\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
[\[6\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
[\[30\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
[\[35\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
[\[39\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
[\[42\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
[\[51\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com)
Triangulation in aetiological epidemiology - PMC - NIH

<https://pmc.ncbi.nlm.nih.gov/articles/PMC5841843/?utm_source=chatgpt.com>

[\[3\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC1898525/?utm_source=chatgpt.com)
The Environment and Disease: Association or Causation?

<https://pmc.ncbi.nlm.nih.gov/articles/PMC1898525/?utm_source=chatgpt.com>

[\[4\]](https://www.cambridge.org/core/journals/psychological-medicine/article/causal-inference-with-observational-data-the-need-for-triangulation-of-evidence/AF5F7918753DF50F26B1D49561F0DF83?utm_source=chatgpt.com)
[\[31\]](https://www.cambridge.org/core/journals/psychological-medicine/article/causal-inference-with-observational-data-the-need-for-triangulation-of-evidence/AF5F7918753DF50F26B1D49561F0DF83?utm_source=chatgpt.com)
[\[54\]](https://www.cambridge.org/core/journals/psychological-medicine/article/causal-inference-with-observational-data-the-need-for-triangulation-of-evidence/AF5F7918753DF50F26B1D49561F0DF83?utm_source=chatgpt.com)
Causal inference with observational data: the need for \...

<https://www.cambridge.org/core/journals/psychological-medicine/article/causal-inference-with-observational-data-the-need-for-triangulation-of-evidence/AF5F7918753DF50F26B1D49561F0DF83?utm_source=chatgpt.com>

[\[7\]](https://www.nature.com/articles/s41591-021-01552-x?utm_source=chatgpt.com)
[\[27\]](https://www.nature.com/articles/s41591-021-01552-x?utm_source=chatgpt.com)
[\[44\]](https://www.nature.com/articles/s41591-021-01552-x?utm_source=chatgpt.com)
Reporting guidelines for human microbiome research

<https://www.nature.com/articles/s41591-021-01552-x?utm_source=chatgpt.com>

[\[8\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC6007885/?utm_source=chatgpt.com)
The impact of dietary transition metals on host-bacterial \... - PMC

<https://pmc.ncbi.nlm.nih.gov/articles/PMC6007885/?utm_source=chatgpt.com>

[\[9\]](https://www.mdpi.com/2304-6740/7/7/80?utm_source=chatgpt.com)
[\[28\]](https://www.mdpi.com/2304-6740/7/7/80?utm_source=chatgpt.com)
[\[29\]](https://www.mdpi.com/2304-6740/7/7/80?utm_source=chatgpt.com)
Role of Nickel in Microbial Pathogenesis

<https://www.mdpi.com/2304-6740/7/7/80?utm_source=chatgpt.com>

[\[10\]](https://pubmed.ncbi.nlm.nih.gov/7298577/?utm_source=chatgpt.com)
Nickel requirement and factor F430 content of \...

<https://pubmed.ncbi.nlm.nih.gov/7298577/?utm_source=chatgpt.com>

[\[11\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC2847644/?utm_source=chatgpt.com)
[\[12\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC2847644/?utm_source=chatgpt.com)
Nutritional immunity beyond iron: a role for manganese and zinc

<https://pmc.ncbi.nlm.nih.gov/articles/PMC2847644/?utm_source=chatgpt.com>

[\[13\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC4993159/?utm_source=chatgpt.com)
[\[47\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC4993159/?utm_source=chatgpt.com)
[\[53\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC4993159/?utm_source=chatgpt.com)
Hepcidin Regulation in the Anemia of Inflammation - PMC - NIH

<https://pmc.ncbi.nlm.nih.gov/articles/PMC4993159/?utm_source=chatgpt.com>

[\[14\]](https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2014.00002/full?utm_source=chatgpt.com)
Transition metal ions at the crossroads of mucosal \...

<https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2014.00002/full?utm_source=chatgpt.com>

[\[15\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC4192467/?utm_source=chatgpt.com)
The Mismetallation of Enzymes during Oxidative Stress - PMC

<https://pmc.ncbi.nlm.nih.gov/articles/PMC4192467/?utm_source=chatgpt.com>

[\[16\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC11209188/?utm_source=chatgpt.com)
Cadmium Exposure: Mechanisms and Pathways of Toxicity \...

<https://pmc.ncbi.nlm.nih.gov/articles/PMC11209188/?utm_source=chatgpt.com>

[\[17\]](https://hero.epa.gov/reference/4648041/?utm_source=chatgpt.com)
Role of calcium channels in heavy metal toxicity - HERO - EPA

<https://hero.epa.gov/reference/4648041/?utm_source=chatgpt.com>

[\[18\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC3087445/?utm_source=chatgpt.com)
Oxidative Stress in Lead and Cadmium Toxicity and Its \... - PMC

<https://pmc.ncbi.nlm.nih.gov/articles/PMC3087445/?utm_source=chatgpt.com>

[\[19\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC8726743/?utm_source=chatgpt.com)
Fiber mixture-specific effect on distal colonic fermentation and \...

<https://pmc.ncbi.nlm.nih.gov/articles/PMC8726743/?utm_source=chatgpt.com>

[\[20\]](https://www.sciencedirect.com/science/article/pii/S0023643825010667?utm_source=chatgpt.com)
Molecular weight variations of partially hydrolyzed guar gum

<https://www.sciencedirect.com/science/article/pii/S0023643825010667?utm_source=chatgpt.com>

[\[21\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC7139284/?utm_source=chatgpt.com)
[\[23\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC7139284/?utm_source=chatgpt.com)
Candida albicans Shields the Periodontal Killer \... - PMC

<https://pmc.ncbi.nlm.nih.gov/articles/PMC7139284/?utm_source=chatgpt.com>

[\[22\]](https://www.mdpi.com/2309-608X/6/1/5?utm_source=chatgpt.com)
Candida spp./Bacteria Mixed Biofilms

<https://www.mdpi.com/2309-608X/6/1/5?utm_source=chatgpt.com>

[\[24\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC12010094/?utm_source=chatgpt.com)
Advancing Gut Microbiome Research: The Shift from \... - PMC

<https://pmc.ncbi.nlm.nih.gov/articles/PMC12010094/?utm_source=chatgpt.com>

[\[25\]](https://www.cell.com/cell/fulltext/S0092-8674%2824%2901038-9?utm_source=chatgpt.com)
[\[45\]](https://www.cell.com/cell/fulltext/S0092-8674%2824%2901038-9?utm_source=chatgpt.com)
A core microbiome signature as an indicator of health

<https://www.cell.com/cell/fulltext/S0092-8674%2824%2901038-9?utm_source=chatgpt.com>

[\[26\]](https://www.sciencedirect.com/science/article/abs/pii/S1047279716300795?utm_source=chatgpt.com)
Challenges for case-control studies with microbiome data

<https://www.sciencedirect.com/science/article/abs/pii/S1047279716300795?utm_source=chatgpt.com>

[\[32\]](https://nickelinstitute.org/en/science/human-health-fact-sheets/fact-sheet-6-low-nickel-diet/?utm_source=chatgpt.com)
Human Health Fact Sheet 6: Low Nickel Diet for \...

<https://nickelinstitute.org/en/science/human-health-fact-sheets/fact-sheet-6-low-nickel-diet/?utm_source=chatgpt.com>

[\[33\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC7071203/?utm_source=chatgpt.com)
[\[34\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC7071203/?utm_source=chatgpt.com)
Irritable Bowel Syndrome-Like Disorders in Endometriosis

<https://pmc.ncbi.nlm.nih.gov/articles/PMC7071203/?utm_source=chatgpt.com>

[\[36\]](https://pubmed.ncbi.nlm.nih.gov/21960508/?utm_source=chatgpt.com)
[\[37\]](https://pubmed.ncbi.nlm.nih.gov/21960508/?utm_source=chatgpt.com)
Remission of endometriosis by hyperbaric oxygen \...

<https://pubmed.ncbi.nlm.nih.gov/21960508/?utm_source=chatgpt.com>

[\[38\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC3662115/?utm_source=chatgpt.com)
A Promise in the Treatment of Endometriosis - PMC - NIH

<https://pmc.ncbi.nlm.nih.gov/articles/PMC3662115/?utm_source=chatgpt.com>

[\[40\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC5656202/?utm_source=chatgpt.com)
Repurposing metformin as a quorum sensing inhibitor \... - PMC

<https://pmc.ncbi.nlm.nih.gov/articles/PMC5656202/?utm_source=chatgpt.com>

[\[41\]](https://link.springer.com/article/10.1007/s10654-024-01194-6?utm_source=chatgpt.com)
[\[43\]](https://link.springer.com/article/10.1007/s10654-024-01194-6?utm_source=chatgpt.com)
[\[50\]](https://link.springer.com/article/10.1007/s10654-024-01194-6?utm_source=chatgpt.com)
Evidence triangulation in health research - Springer Nature

<https://link.springer.com/article/10.1007/s10654-024-01194-6?utm_source=chatgpt.com>

[\[46\]](https://www.pasteur.fr/en/medical-center/disease-sheets/group-and-b-streptococcus?utm_source=chatgpt.com)
Group A and B Streptococcus - Institut Pasteur

<https://www.pasteur.fr/en/medical-center/disease-sheets/group-and-b-streptococcus?utm_source=chatgpt.com>

[\[48\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC3752295/?utm_source=chatgpt.com)
Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal \...

<https://pmc.ncbi.nlm.nih.gov/articles/PMC3752295/?utm_source=chatgpt.com>

[\[49\]](https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1008029&utm_source=chatgpt.com)
Deciphering the interplay between the genotoxic and probiotic \...

<https://journals.plos.org/plospathogens/article?id=10.1371%2Fjournal.ppat.1008029&utm_source=chatgpt.com>

[\[52\]](https://pmc.ncbi.nlm.nih.gov/articles/PMC12192176/?utm_source=chatgpt.com)
Diet and Endometriosis: An Umbrella Review - PMC

<https://pmc.ncbi.nlm.nih.gov/articles/PMC12192176/?utm_source=chatgpt.com>
